Searched for
US PHARMACEUTICAL SITE
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...17 Sep, 2026, 11.05 AM IST- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...15 Sep, 2026, 11.21 AM IST
- India’s semiconductor push will need a new approach to water management: CN WaterIndia’s semiconductor push is creating a new demand for smarter, more reliable water infrastructure. CN Water’s Shoeb Kurawadwala on locali...15 Sep, 2026, 10.23 AM IST
- How ‘brave’ small-town club Elversberg is shaking up German footballElversberg, the Bundesliga's smallest team, achieved a remarkable start to their top-flight campaign. They secured two surprising victories...06 Sep, 2026, 12.22 AM IST
- After Adani, Tata feels the heat: Indian firms under fire in Kenya?Kenya’s dispute with Tata Chemicals has revived concerns about Indian businesses in the country after Adani’s exit. But Kenya continues to ...04 Sep, 2026, 05.44 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...03 Sep, 2026, 11.55 AM IST
- India-Uzbekistan ties go comprehensive as Modi, Mirziyoyev set $5 billion trade goalIndia and Uzbekistan elevated their relationship to a Comprehensive Strategic Partnership. They set an ambitious target of five billion dol...30 Aug, 2026, 06.53 PM IST
- Exxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reportsShell is reportedly seeking to sell its U.S. chemical assets for up to eight billion dollars. Several major companies and a private equity ...24 Aug, 2026, 10.31 AM IST
- Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...20 Aug, 2026, 11.09 AM IST
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...06 Aug, 2026, 01.04 PM IST
- ETMarkets AIF Talk| Successful private credit rests on three pillars: promoter, business and collateral: Sandeep AgarwalIn this edition of ETMarkets AIF Talk, Sandeep Agarwal, CEO & CIO of Modulus Alternatives, explains why successful private credit investing...06 Aug, 2026, 08.03 AM IST
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...31 Jul, 2026, 01.24 AM IST
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...27 Jul, 2026, 12.52 PM IST
- EU hits AliExpress with a record 550 million-euro fine over unsafe and counterfeit goodsThe European Commission has fined AliExpress 550 million euros for failing to stop unsafe products. This significant penalty is the largest...20 Jul, 2026, 05.31 PM IST
- Sun Pharma gets USFDA nod for eye inflammation drugThe company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.10 Apr, 2016, 01.45 PM IST
- Dilip Shanghvi's Sun pharma sets sights on InSite Vision of US; deal may be valued at about Rs 300 croreSun Pharmaceutical Industries has bid to acquire US eye care company InSite Vision to expand its basket of specialty products and boost sal...16 Sep, 2015, 05.05 PM IST
Load More
